David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
CALL
Criteo S.A.
CRTO
$837M
| $361K | ﹤0.01% |
+10,400
| New | +$286K |
|
3502
PUT
Magna International
MGA
$18.1B
| $361K | ﹤0.01% |
+4,100
| New | +$333K |
|
3503
PUT
Cimpress
CMPR
$2.13B
| $360K | ﹤0.01% |
3,600
| – | – |
|
3504
OneMain Financial
OMF
$7.23B
| $359K | ﹤0.01% |
6,679
-62,311
| -90% | -$3.22M |
|
3505
PUT
Frontline
FRO
$9.81B
| $358K | ﹤0.01% |
50,000
| – | – |
|
3506
Comfort Systems
FIX
$56.7B
| $357K | ﹤0.01% |
4,780
-1,848
| -28% | -$118K |
|
3507
PUT
Scorpio Tankers
STNG
$3.92B
| $356K | ﹤0.01% |
19,300
+3,000
| +18% | +$46.4K |
|
|
LNW
3508
DELISTED
Light & Wonder
LNW
| $355K | ﹤0.01% |
9,219
-14,697
| -61% | -$659K |
|
|
CPE
3509
PUT
DELISTED
Callon Petroleum Company
CPE
| $355K | ﹤0.01% |
+9,200
| New | +$228K |
|
|
CVET
3510
DELISTED
Covetrus, Inc. Common Stock
CVET
| $355K | ﹤0.01% |
11,842
-56,735
| -83% | -$1.93M |
|
3511
PUT
Suncor Energy
SU
$78.8B
| $351K | ﹤0.01% |
16,800
-34,100
| -67% | -$668K |
|
|
BGRY
3512
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $350K | ﹤0.01% |
+34,513
| New | +$372K |
|
3513
James Hardie Industries
JHX
$17.5B
| $348K | ﹤0.01% |
11,508
-3,233
| -22% | -$96K |
|
3514
CALL
CME Group
CME
$100B
| $347K | ﹤0.01% |
+1,700
| New | +$335K |
|
|
ICPT
3515
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $346K | ﹤0.01% |
14,994
+25
| +0.2% | +$697 |
|
3516
WesBanco
WSBC
$3.91B
| $344K | ﹤0.01% |
+9,542
| New | +$314K |
|
|
CNCE
3517
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $344K | ﹤0.01% |
68,829
+10,756
| +19% | +$86.9K |
|
3518
Evertec
EVTC
$1.77B
| $341K | ﹤0.01% |
9,159
-2,018
| -18% | -$75.9K |
|
3519
PUT
Ventas
VTR
$47.9B
| $341K | ﹤0.01% |
6,400
-57,700
| -90% | -$2.96M |
|
3520
Designer Brands
DBI
$297M
| $339K | ﹤0.01% |
19,482
-149,705
| -88% | -$1.88M |
|
3521
Certara
CERT
$1.21B
| $338K | ﹤0.01% |
+12,397
| New | +$412K |
|
3522
Navigator Holdings
NVGS
$1.37B
| $338K | ﹤0.01% |
38,002
-34,319
| -47% | -$348K |
|
3523
PUT
Winnebago Industries
WGO
$909M
| $338K | ﹤0.01% |
4,400
-15,600
| -78% | -$1.13M |
|
|
LKFT
3524
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.9B
| $337K | ﹤0.01% |
+4,372
| New | +$403K |
|
3525
Kforce
KFRC
$1.03B
| $337K | ﹤0.01% |
6,279
-135
| -2% | -$6.53K |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.